Over the last 5 years, the share price of Golkunda Diamonds & Jewellery has gained 75.21% CAGR. Over the past year, the corresponding return has been 27.14%. Golkunda Diamonds & Jewellery’s current ...

Black Diamond Therapeutics, Inc., a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company’s lead ...

Blue Diamond Ventures, Inc. focuses on opportunities in various industries related to agriculture, renewable energies, and natural holistic products and services derived from botanicals. The company, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...